NYSE:MDT Medtronic (MDT) Stock Price, News & Analysis → Biden’s Tax Plan Could Destroy Your Retirement Savings! (From GoldenCrest Metals) (Ad) Free MDT Stock Alerts $81.04 -0.62 (-0.76%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$80.52▼$81.5450-Day Range$79.08▼$85.9252-Week Range$68.84▼$91.00Volume3.68 million shsAverage Volume6.26 million shsMarket Capitalization$107.61 billionP/E Ratio29.47Dividend Yield3.41%Price Target$93.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Medtronic alerts: Email Address Medtronic MarketRank™ Stock AnalysisAnalyst RatingHold2.25 Rating ScoreUpside/Downside14.8% Upside$93.00 Price TargetShort InterestHealthy1.02% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-1.28Upright™ Environmental ScoreNews Sentiment0.75Based on 24 Articles This WeekInsider TradingSelling Shares$1.67 M Sold Last QuarterProj. Earnings Growth7.35%From $5.44 to $5.84 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.97 out of 5 starsMedical Sector13th out of 915 stocksElectromedical Equipment Industry1st out of 19 stocks 3.1 Analyst's Opinion Consensus RatingMedtronic has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 5 buy ratings, 5 hold ratings, and 2 sell ratings.Amount of Analyst CoverageMedtronic has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Medtronic's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.02% of the float of Medtronic has been sold short.Short Interest Ratio / Days to CoverMedtronic has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medtronic has recently decreased by 13.11%, indicating that investor sentiment is improving significantly. Previous Next 3.3 Dividend Strength Dividend YieldMedtronic pays a meaningful dividend of 3.36%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMedtronic has been increasing its dividend for 48 years.Dividend CoverageThe dividend payout ratio of Medtronic is 100.36%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Medtronic will have a dividend payout ratio of 47.26% next year. This indicates that Medtronic will be able to sustain or increase its dividend.Read more about Medtronic's dividend. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedtronic has received a 57.41% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Surgical instruments for cardiac surgery", "Insulin pumps", "Wound closure devices", "Antiarrhythmic agents", "Surgical instruments", and "Synthetic bone grafts" products. See details.Environmental SustainabilityThe Environmental Impact score for Medtronic is -1.28. Previous Next 3.2 News and Social Media Coverage News SentimentMedtronic has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 24 news articles for Medtronic this week, compared to 16 articles on an average week.Search Interest57 people have searched for MDT on MarketBeat in the last 30 days. This is an increase of 2% compared to the previous 30 days.MarketBeat Follows76 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 12% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medtronic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,672,098.00 in company stock.Percentage Held by InsidersOnly 0.30% of the stock of Medtronic is held by insiders.Percentage Held by Institutions82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medtronic's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Medtronic are expected to grow by 7.35% in the coming year, from $5.44 to $5.84 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medtronic is 29.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 141.23.Price to Earnings Ratio vs. SectorThe P/E ratio of Medtronic is 29.47, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 151.64.Price to Earnings Growth RatioMedtronic has a PEG Ratio of 2.40. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMedtronic has a P/B Ratio of 2.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Medtronic's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Oxford ClubYour "AI Income Playbook" Awaits...Today, he wants to give you his "AI Income Playbook"... FREE of charge! Inside, you'll discover Marc's favorite AI dividend stocks... Complete with their names, ticker symbols, and full breakdown of their massive income potential.Click here now to claim your FREE copy of Marc's AI playbook. About Medtronic Stock (NYSE:MDT)Medtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.Written by Jeffrey Neal JohnsonRead More MDT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDT Stock News HeadlinesJune 12 at 5:54 AM | insidertrades.comMedtronic plc (NYSE:MDT) CEO Geoffrey Martha Sells 19,113 SharesMay 24, 2024 | marketbeat.comMedtronic Dips: Is Now the Time to Buy?Shares of Medtronic NYSE: MDT are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow are enough to keep investors interested and if they should be.May 24, 2024 | marketbeat.comMedtronic Dips: Is Now the Time to Buy?Medtronic had another stable quarter with FCF growth and healthy capital returns. Analysts Hold the stock and see it advancing 15% at the midpoint.May 16, 2024 | marketbeat.com5 Companies Leading the Charge With Robotic SolutionsSince the mid-1900s, modern robotics has captivated our collective imagination. The prospect of machines performing tasks once exclusive to humans is both thrilling and, for some, a bit disturbing.May 16, 2024 | marketbeat.com5 Companies Leading the Charge With Robotic Solutions (MDT)Recent AI innovations have aided and advanced robotics, which is reshaping industries by automating tasks and garnering a surge in global investments.June 14 at 4:30 PM | prnewswire.comBetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLCJune 14 at 6:15 AM | fool.comGot $200? 2 Healthcare Stocks to Buy and Hold Forever.June 14 at 3:00 AM | seekingalpha.comMedtronic: Why I Disagree With The CrowdJune 13 at 5:02 AM | americanbankingnews.comGeoffrey Martha Sells 19,113 Shares of Medtronic plc (NYSE:MDT) StockJune 12 at 9:15 AM | benzinga.comWall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend YieldsJune 11 at 7:07 PM | investing.comMedtronic CEO Martha Geoffrey sells shares worth over $1.6 millionJune 11 at 6:18 PM | seekingalpha.comMedtronic plc (MDT) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)June 8, 2024 | americanbankingnews.comMedtronic (NYSE:MDT) Trading Up 0.3%June 7, 2024 | americanbankingnews.comMedtronic (NYSE:MDT) Rating Reiterated by Royal Bank of CanadaJune 6, 2024 | insidermonkey.comMedtronic plc (NYSE:MDT): The Best Healthcare Dividend Aristocrat Stock To Buy?June 6, 2024 | prnewswire.comMedtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conferenceJune 6, 2024 | fool.comMedtronic Raised Its Dividend for a 47th Straight Year, But Here's Why It Isn't a Great Dividend Growth StockJune 5, 2024 | investorplace.comDividend Delights: 3 Stocks That Will Sweeten Your Investment ReturnsJune 3, 2024 | investorplace.com7 Overlooked Stocks Offering Long-Term Stability From the ShadowsJune 3, 2024 | prnewswire.comMedtronic announces closing of public offering of €3.0 billion of senior notesJune 3, 2024 | investorplace.comBeat the Heat: 3 Stocks to Buy Before the Summer Slowdown Sets InJune 1, 2024 | fool.comIs Medtronic Stock a Buy?May 30, 2024 | fool.comMedtronic Stock Is a Sell, According to 1 Wall Street AnalystMay 29, 2024 | prnewswire.comMedtronic announces pricing of €3.0 billion of senior notesMay 29, 2024 | investorplace.comThe 3 Best MedTech Stocks to Buy Now: May 2024See More Headlines Receive MDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/12 Dividend3/21/2024Dividend Payable4/12/2024Last Earnings5/23/2024Today6/14/2024Ex-Dividend for 7/12 Dividend6/28/2024Dividend Payable7/12/2024Next Earnings (Estimated)8/27/2024Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Electromedical equipment Sub-IndustryHealth Care Equipment Current SymbolNYSE:MDT CUSIP58505510 CIK1613103 Webwww.medtronic.com Phone(531) 438-1700Fax763-514-4879Employees95,000Year Founded1949Price Target and Rating Average Stock Price Target$93.00 High Stock Price Target$106.00 Low Stock Price Target$76.00 Potential Upside/Downside+14.8%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)$2.75 Trailing P/E Ratio29.47 Forward P/E Ratio14.90 P/E Growth2.4Net Income$3.68 billion Net Margins11.36% Pretax Margin14.95% Return on Equity13.47% Return on Assets7.65% Debt Debt-to-Equity Ratio0.47 Current Ratio2.03 Quick Ratio1.55 Sales & Book Value Annual Sales$32.36 billion Price / Sales3.32 Cash Flow$7.10 per share Price / Cash Flow11.41 Book Value$37.97 per share Price / Book2.13Miscellaneous Outstanding Shares1,327,820,000Free Float1,323,840,000Market Cap$107.61 billion OptionableOptionable Beta0.83 Social Links 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Geoffrey Straub Martha (Age 54)Chairman of the Board & CEO Comp: $1.79MMs. Karen L. Parkhill (Age 59)Executive VP & CFO Comp: $992.24kMr. Sean M. Salmon (Age 59)Executive VP & President of Cardiovascular Portfolio Comp: $900.97kMr. Robert J. W. ten Hoedt (Age 64)Executive VP & President of Global Regions Comp: $1.24MMr. Mark PloofSenior Vice President of Global Operations and Business ServicesMs. Jennifer M. Kirk (Age 49)Senior VP, Global Controller & Chief Accounting Officer Dr. Kenneth E. Washington Ph.D. (Age 64)Senior VP and Chief Technology & Innovation Officer Dr. Laura Mauri M.D.M.Sc., Senior VP and Chief Scientific & Medical OfficerMr. Ryan WeispfenningVP & Head of Investor RelationsMr. Ivan K. Fong (Age 63)Executive VP, General Counsel & Secretary Comp: $985.57kMore ExecutivesKey CompetitorsAbbott LaboratoriesNYSE:ABTIntuitive SurgicalNASDAQ:ISRGStrykerNYSE:SYKBoston ScientificNYSE:BSXBecton, Dickinson and CompanyNYSE:BDXView All CompetitorsInsiders & InstitutionsKeynote Financial Services LLCBought 8,522 shares on 6/13/2024Ownership: 0.001%Cypress Asset Management Inc. TXSold 200 shares on 6/11/2024Ownership: 0.002%American TrustSold 835 shares on 6/11/2024Ownership: 0.001%OMC Financial Services LTDBought 5,980 shares on 6/11/2024Ownership: 0.000%EverSource Wealth Advisors LLCBought 380 shares on 6/11/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions Should I Buy Medtronic Stock? MDT Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Medtronic plc: Medtronic plc has shown consistent revenue growth over the past year, indicating a strong financial performance. The company's latest product innovations, such as the Medtronic Guardian Connect system, have received positive reviews and are expected to drive future sales. Medtronic plc's stock price has been steadily increasing, reflecting investor confidence in the company's future prospects. The company has a diverse product portfolio in the medical technology sector, reducing dependency on any single product or market. Medtronic plc has a strong global presence, allowing it to capitalize on emerging markets and international growth opportunities. Cons Investors should be bearish about investing in Medtronic plc for these reasons: Increased competition in the medical technology industry could put pressure on Medtronic plc's market share and margins. Regulatory challenges and changes in healthcare policies could impact the company's ability to bring new products to market or affect reimbursement rates. Fluctuations in foreign exchange rates may expose Medtronic plc to currency risk, especially with its global operations. Any disruptions in the global supply chain could affect Medtronic plc's manufacturing and distribution capabilities, impacting sales and profitability. Economic downturns or recessions could lead to reduced healthcare spending, affecting demand for Medtronic plc's products and services. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, June 4, 2024. Please send any questions or comments about these Medtronic pros and cons to contact@marketbeat.com. MDT Stock Analysis - Frequently Asked Questions Should I buy or sell Medtronic stock right now? 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 2 sell ratings, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares. View MDT analyst ratings or view top-rated stocks. What is Medtronic's stock price target for 2024? 12 brokers have issued 12-month price targets for Medtronic's shares. Their MDT share price targets range from $76.00 to $106.00. On average, they expect the company's share price to reach $93.00 in the next twelve months. This suggests a possible upside of 14.8% from the stock's current price. View analysts price targets for MDT or view top-rated stocks among Wall Street analysts. How have MDT shares performed in 2024? Medtronic's stock was trading at $82.38 at the beginning of 2024. Since then, MDT shares have decreased by 1.6% and is now trading at $81.04. View the best growth stocks for 2024 here. When is Medtronic's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 27th 2024. View our MDT earnings forecast. How were Medtronic's earnings last quarter? Medtronic plc (NYSE:MDT) announced its quarterly earnings data on Thursday, May, 23rd. The medical technology company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.01. The medical technology company had revenue of $8.59 billion for the quarter, compared to analysts' expectations of $8.44 billion. Medtronic had a net margin of 11.36% and a trailing twelve-month return on equity of 13.47%. The firm's revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.57 earnings per share. Read the conference call transcript. How often does Medtronic pay dividends? What is the dividend yield for Medtronic? Medtronic announced a quarterly dividend on Wednesday, May 22nd. Investors of record on Friday, June 28th will be paid a dividend of $0.70 per share on Friday, July 12th. This represents a $2.80 annualized dividend and a yield of 3.46%. The ex-dividend date is Friday, June 28th. This is a positive change from the stock's previous quarterly dividend of $0.69. Read our dividend analysis for MDT. Is Medtronic a good dividend stock? Medtronic (NYSE:MDT) pays an annual dividend of $2.76 per share and currently has a dividend yield of 3.36%. The company has been increasing its dividend for 48 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 100.36%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 47.26% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for MDT. What ETFs hold Medtronic's stock? ETFs with the largest weight of Medtronic (NYSE:MDT) stock in their portfolio include American Century Focused Large Cap Value ETF (FLV), iShares U.S. Medical Devices ETF (IHI), Absolute Select Value ETF (ABEQ), VanEck Morningstar Wide Moat Value ETF (MVAL), Leatherback Long/Short Alternative Yield ETF (LBAY), Madison Dividend Value ETF (DIVL), Cambiar Aggressive Value ETF (CAMX) and USCF Dividend Income Fund (UDI). What guidance has Medtronic issued on next quarter's earnings? Medtronic issued an update on its FY 2025 earnings guidance on Friday, May, 24th. The company provided EPS guidance of 5.400-5.500 for the period, compared to the consensus earnings per share estimate of 5.450. The company issued revenue guidance of $33.1 billion-$33.6 billion, compared to the consensus revenue estimate of $33.6 billion. What is Omar S. Ishrak's approval rating as Medtronic's CEO? 1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Medtronic own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT). Who are Medtronic's major shareholders? Medtronic's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.51%), Capital Research Global Investors (2.33%), Bank of New York Mellon Corp (1.64%), Price T Rowe Associates Inc. MD (1.12%), First Eagle Investment Management LLC (0.71%) and Pzena Investment Management LLC (0.58%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Carol A Surface, Geoffrey Martha, Gregory L Smith, Hoedt Rob Ten, Karen L Parkhill, Karen L Parkhill, Michael Marinaro, Richard H Anderson, Robert John White and Sean Salmon. View institutional ownership trends. How do I buy shares of Medtronic? Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:MDT) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medtronic plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medtronic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.